Increase in specialty drug spending to continue

04/12/2013 | Wall Street Journal, The

Spending on specialty drugs is expected to rise continually in the next few years, partly because of a stronger pipeline for such medicines than for nonspecialty treatments, CVS Caremark said. The prices of specialty drugs can be higher because they target only a fragment of the population and face little competition.

View Full Article in:

Wall Street Journal, The

Published in Brief: